Company intelligence / Profile preview

Virginia Catalyst

Richmond, Virginia, United States

Ownership: Private
Development stage: Other

Overview

Virginia Catalyst is a nonprofit research consortium that provides competitive grant funding and strategic initiatives to accelerate translational life science research, commercialization, and job creation in Virginia, but it does not itself develop therapeutic products or run a drug pipeline.

Industry: Investors

Partnerships

Eastern Virginia Medical School (founding member institution)George Mason University (founding member institution)Old Dominion UniversityUniversity of VirginiaVirginia Commonwealth UniversityVirginia TechWilliam & MaryMultiple Virginia health systems and life science companies via funded collaborations (e.g., Adovate, Lytos Technologies, Pascal Medical Corporation, S1P Therapeutics, Evizia, MGMedicine, SlateBio)

Beyond the preview

Go deeper on Virginia Catalyst.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Virginia Catalyst.

Explore the full profile